+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Analysis Report on the Blood Fat Capitulating Medicine Market in China

  • ID: 45943
  • Report
  • February 2004
  • Region: China
  • 11 pages
  • Sunfaith China Ltd
1 of 4
The report first gives an introduction to the general situation of the blood fat capitulating medicines in China, pointing out the ascending trend in the market. Then, the report analyzes the two consumption modes of the blood fat capitulating medicines: the mode of health care products and the mode of medicines and makes the contrast between the two modes.

Analysis on the main medicines in the market is given later in the report, which attaches great importance to the genaissance pharmaceuticals. The report also gives a brief introduction to the non Genaissance Pharmaceuticals. The contrast between the two kinds of the medicines in terms of the development trend is given in the report.

Note: Product cover images may vary from those shown
2 of 4

Loading
LOADING...

3 of 4
1. introduction
1.1 brief introduction to the high blood fat
1.2 introduction to the blood fat capitulating medicines
2.analysis on the sales mode of blood fat capitulating medicines
2.1 the consumption mode of health care products
2.2 the consumption mode of medicines
2.3 contrast between the two consumption modes
3 analysis on the key blood fat capitulating medicines
3.1 Genaissance Pharmaceuticals
3.1.1 Lovastatin
3.1.2 pravastatin
3.1.3 Simvastatin
3.1.4 fluvastatin
3.2 non- Genaissance Pharmaceuticals
4. Summaries

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll